I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Calinisan, Andrew
9
results:
Search for persons
X
Format
Online (9)
Mediatypes
Articles (Online) (4)
OpenAccess-fulltext (5)
Sorted by: Relevance
Sorted by: Year
?
1
Discovery of Pyridopyrimidinones that Selectively Inhibit t..:
Ketcham, John M.
;
Harwood, Stephen J.
;
Aranda, Ruth
...
Journal of Medicinal Chemistry. 67 (2024) 6 - p. 4936-4949 , 2024
Link:
https://doi.org/10.1021/..
?
2
The SOS1 Inhibitor MRTX0902 Blocks KRAS Activation and Demo..:
Sudhakar, Niranjan
;
Yan, Larry
;
Qiryaqos, Fadia
...
Molecular Cancer Therapeutics. , 2024
Link:
https://doi.org/10.1158/..
?
3
Anti-tumor efficacy of a potent and selective non-covalent ..:
Hallin, Jill
;
Bowcut, Vickie
;
Calinisan, Andrew
...
Nature Medicine. 28 (2022) 10 - p. 2171-2182 , 2022
Link:
https://doi.org/10.1038/..
?
4
Identification of MRTX1133, a Noncovalent, Potent, and Sele..:
Wang, Xiaolun
;
Allen, Shelley
;
Blake, James F.
...
Journal of Medicinal Chemistry. 65 (2021) 4 - p. 3123-3133 , 2021
Link:
https://doi.org/10.1021/..
?
5
The KRAS(G12C) Inhibitor MRTX849 Reconditions the Tumor Imm..:
Briere, David M
;
Li, Shuai
;
Calinisan, Andrew
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8444277/. , 2021
Link:
http://www.ncbi.nlm.nih...
?
6
The KRAS(G12C) Inhibitor, MRTX849, Provides Insight Toward ..:
Hallin, Jill
;
Engstrom, Lars D
;
Hargis, Lauren
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6954325/. , 2019
Link:
http://www.ncbi.nlm.nih...
?
7
The KRASG12C Inhibitor MRTX849 Provides Insight toward Ther..:
Jill Hallin
;
Lars D. Engstrom
;
Lauren Hargis
...
doi:10.5281/zenodo.3637579. , 2019
Link:
https://zenodo.org/recor..
?
8
Identification of MRTX1133, a Noncovalent, Potent, and Sele..:
Xiaolun Wang (2252662)
;
Shelley Allen (1860448)
;
James F. Blake (2039950)
...
https://figshare.com/articles/dataset/Identification_of_MRTX1133_a_Noncovalent_Potent_and_Selective_KRAS_sup_G12D_sup_Inhibitor/17159271. , 2021
Link:
https://doi.org/10.1021/..
?
9
Identification of MRTX1133, a Noncovalent, Potent, and Sele..:
Xiaolun Wang (2252662)
;
Shelley Allen (1860448)
;
James F. Blake (2039950)
...
https://figshare.com/articles/journal_contribution/Identification_of_MRTX1133_a_Noncovalent_Potent_and_Selective_KRAS_sup_G12D_sup_Inhibitor/17159268. , 2021
Link:
https://doi.org/10.1021/..
1-9
